Stock Ratings / Health Care / BFRG / earnings

MBRX (43) INM (47) PHIO (42) PTN (38) ⌘ Pro Terminal →

Bullfrog AI Holdings Inc. (BFRG) Next Earnings Date & Expected ±12.5% Move

$0.51 +3.88% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Bullfrog AI Holdings Inc. (BFRG) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $9.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-7.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BFRG)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.06 Expected Swing

MODEL EARNINGS SETUP GAUGE

BFRG Quantitative Pre-Earnings Setup: 40/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (40/100)Model Risk Weight (60/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$116.7K	-$6.5M	-$5.5M	18.8%
FY 2024	2024-12-31	$0	-$7.0M	-$5.6M	18.8%
FY 2023	2023-12-31	$65.0K	-$5.4M	-$6.0M	18.8%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BFRG)

✓Walkthrough of BFRG's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BFRG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -27.14%📐 HORIZONTAL RANGE

2026-10-30O $0.49H $0.51L $0.48C $0.51VOL 125.2K

RES: $1.13SUP: $0.34SMA50: $0.56SMA200: $0.65

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BFRG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BFRG Butterfly Map → + Track BFRG →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BFRG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BFRG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BFRG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BFRG)

Health Care Rank #653 of 1016 ⚔️ MBRX vs BFRG Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BFRG vs. MBRX, INM, PHIO, PTN)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Bullfrog AI Holdings Inc. (BFRG) ranks #653 by composite RQD confidence (40/100, grade D-) and #900 by equity capitalization ($9.4M). Within this direct 5-issuer industry benchmark cohort, BFRG leads on earnings valuation at N/A trailing P/E, while BFRG leads on capital efficiency and profitability with -35.0% ROIC and 18.8% gross margin. INM currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with BFRG at 40/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BFRG ACTIVE Bullfrog AI Holdings Inc.	D-	40/100	—	18.8%	-35.0%	+3.88%	$9.4M	Benchmark Subject
MBRX Moleculin Biotech Inc.	D-	43/100	—	—	-35.0%	-0.29%	$9.2M	/mbrx-vs-bfrg →
INM InMed Pharmaceuticals Inc.	D	47/100	—	34.5%	-35.0%	+1.61%	$8.9M	/inm-vs-bfrg →
PHIO Phio Pharmaceuticals Corp.	D-	42/100	—	—	-35.0%	-5.91%	$10.0M	/phio-vs-bfrg →
PTN Palatin Technologies Inc.	D-	38/100	—	—	-35.0%	-3.33%	$8.8M	/ptn-vs-bfrg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001829247

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Bullfrog AI Holdings Inc. (BFRG) reported GAAP revenue of $116.7K (N/A vs. FY2024 revenue of $0 , and +79.5% cumulative change since FY2023) , GAAP net income of -$6.5M, operating cash flow of -$5.5M, and free cash flow of -$5.5M (+1.6% YoY). On the balance sheet, BFRG closed FY2025 with $2.8M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$116.7K	-$6.5M	-$5.5M	-$5.5M	$2.8M	—
FY2024 (FY)	2024-12-31	$0	-$7.0M	-$5.6M	-$5.6M	$5.6M	—
FY2023 (FY)	2023-12-31	$65.0K	-$5.4M	-$6.0M	-$6.0M	—	—

3. BFRG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BFRG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Bullfrog AI Holdings Inc. (NASDAQ: BFRG) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $0.51 (+3.88% 1D, market cap $9.4M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BFRG ranks #653 in composite RQD confidence.

How does BFRG compare to MBRX and INM in the Health Care sector?

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), BFRG carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 18.8%, and ROIC of -35.0%. By comparison, MBRX (Moleculin Biotech Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $9.2M) and INM (InMed Pharmaceuticals Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC -35.0%, cap $8.9M). Among the 5-stock peer group, BFRG leads on earnings multiple (N/A) while BFRG leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BFRG?

Per BFRG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001829247), Bullfrog AI Holdings Inc. generated $116.7K in revenue, -$6.5M in net income, and -$5.5M in free cash flow against $2.8M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BFRG trading relative to its 50-day, 200-day, and 52-week technical levels?

BFRG last traded at $0.51 (+3.88% on volume of 157,326 shares), positioning the stock -8.93% below its 50-day simple moving average ($0.56) and -21.54% below its 200-day simple moving average ($0.65). Across its 52-week range of $0.43 to $1.96, BFRG sits at the 5.2% percentile with a 14-day RSI of 43.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.57).